APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.

[1]  Tatsuya Kato,et al.  Overexpression of CDC20 predicts poor prognosis in primary non‐small cell lung cancer patients , 2012, Journal of surgical oncology.

[2]  M. Malumbres,et al.  Cdh1 regulates osteoblast function through an APC/C-independent modulation of Smurf1. , 2011, Molecular cell.

[3]  D. Sliva,et al.  Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA. , 2011, Biochemical and biophysical research communications.

[4]  G. Melino,et al.  Cell death pathology: the war against cancer. , 2011, Biochemical and biophysical research communications.

[5]  W. Gu,et al.  p53 regulation by ubiquitin , 2011, FEBS letters.

[6]  W. Kaelin,et al.  Good COP1 or bad COP1? In vivo veritas. , 2011, The Journal of clinical investigation.

[7]  Fiona A. Stewart,et al.  Strategies to improve radiotherapy with targeted drugs , 2011, Nature Reviews Cancer.

[8]  Adam R. Johnson,et al.  Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7 , 2011, Nature.

[9]  P. Goel,et al.  Cyclic‐AMP‐dependent protein kinase A regulates apoptosis by stabilizing the BH3‐only protein Bim , 2011, EMBO reports.

[10]  M. Malumbres,et al.  Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase. , 2010, Cancer cell.

[11]  A. Strasser,et al.  Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. , 2010, Blood.

[12]  Osamu Takeuchi,et al.  BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program , 2010, Science.

[13]  D. Oh,et al.  Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. , 2010, Cancer cell.

[14]  D. Green,et al.  The BCL-2 family reunion. , 2010, Molecular cell.

[15]  C. Scott,et al.  c-Cbl Promotes T Cell Receptor-induced Thymocyte Apoptosis by Activating the Phosphatidylinositol 3-Kinase/Akt Pathway* , 2010, The Journal of Biological Chemistry.

[16]  M. Kirschner,et al.  UBE2S drives elongation of K11-linked ubiquitin chains by the Anaphase-Promoting Complex , 2010, Proceedings of the National Academy of Sciences.

[17]  T. Mitchison,et al.  Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. , 2009, Cancer cell.

[18]  A. Strasser,et al.  Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics , 2009, Nature Reviews Cancer.

[19]  A. Toker,et al.  Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction , 2009, Nature Cell Biology.

[20]  Michael S. Cohen,et al.  betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis. , 2009, Molecular cell.

[21]  Jeremy Minshull,et al.  The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction , 2008, Nature Cell Biology.

[22]  Dafydd G. Thomas,et al.  Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. , 2008, Cancer research.

[23]  N. Tjandra,et al.  BAX Activation is Initiated at a Novel Interaction Site , 2008, Nature.

[24]  Stephen S. Taylor,et al.  Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. , 2008, Cancer cell.

[25]  J. Cheng,et al.  RACK1 and CIS Mediate the Degradation of BimEL in Cancer Cells* , 2008, Journal of Biological Chemistry.

[26]  Y. Furukawa,et al.  CDC20, a potential cancer therapeutic target, is negatively regulated by p53 , 2008, Oncogene.

[27]  A. Letai,et al.  BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. , 2007, Cancer cell.

[28]  M. Pagano,et al.  APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. , 2007, Molecular cell.

[29]  Hongtao Yu,et al.  Cdc20: a WD40 activator for a cell cycle degradation machine. , 2007, Molecular cell.

[30]  M. Kirschner,et al.  Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation , 2007, Nature.

[31]  Kuan-Teh Jeang,et al.  Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation , 2007, Nature Reviews Cancer.

[32]  S. Armstrong,et al.  Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.

[33]  J. Diffley,et al.  CDKs Promote DNA Replication Origin Licensing in Human Cells by Protecting Cdc6 from APC/C-Dependent Proteolysis , 2005, Cell.

[34]  R. Perez-soler,et al.  Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants. , 2005, Cancer research.

[35]  E. White,et al.  Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. , 2005, Cancer cell.

[36]  T. Kuwana,et al.  BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. , 2005, Molecular cell.

[37]  Hongtao Yu,et al.  HTLV-I Tax directly binds the Cdc20-associated anaphase-promoting complex and activates it ahead of schedule. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Y. Sánchez,et al.  The DNA damage checkpoint and PKA pathways converge on APC substrates and Cdc20 to regulate mitotic progression , 2004, Nature Cell Biology.

[39]  Jun Qin,et al.  SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. , 2003, Genes & development.

[40]  J Wade Harper,et al.  The anaphase-promoting complex: it's not just for mitosis any more. , 2002, Genes & development.

[41]  S. Korsmeyer,et al.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. , 2002, Cancer cell.

[42]  J. Peters,et al.  Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 , 2002, The Journal of cell biology.

[43]  P. Jackson,et al.  Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins. , 2001, Genes & development.

[44]  A. Strasser,et al.  Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. , 1999, Science.

[45]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[46]  M. Kirschner,et al.  The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. , 1998, Genes & development.

[47]  M. Moskowitz,et al.  Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Marc W. Kirschner,et al.  How Proteolysis Drives the Cell Cycle , 1996, Science.

[49]  Yonghong Xiao,et al.  SCFFBW 7 regulates cellular apoptosis by targeting MCL 1 for ubiquitylation and destruction , 2011 .

[50]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.